Rhamnetin

CAS No. 90-19-7

Rhamnetin( beta-Rhamnocitrin )

Catalog No. M29098 CAS No. 90-19-7

Rhamnetin, a quercetin derivative found in Coriandrum sativum, has antioxidant and anti-inflammatory activities. Rhamnetin inhibits secretory phospholipase A2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 140 In Stock
5MG 132 In Stock
10MG 211 In Stock
25MG 356 In Stock
50MG 513 In Stock
100MG 732 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rhamnetin
  • Note
    Research use only, not for human use.
  • Brief Description
    Rhamnetin, a quercetin derivative found in Coriandrum sativum, has antioxidant and anti-inflammatory activities. Rhamnetin inhibits secretory phospholipase A2.
  • Description
    Rhamnetin, a quercetin derivative found in Coriandrum sativum, has antioxidant and anti-inflammatory activities. Rhamnetin inhibits secretory phospholipase A2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    beta-Rhamnocitrin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    90-19-7
  • Formula Weight
    316.265
  • Molecular Formula
    C16H12O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 6,11-Di-O-acetylalbr...

    6,11-Di-O-acetylalbrassitriol is a metabolite produced by Alternaria brassicae, the black spot pathogen of oilseed rape.

  • 6,7-Dihydroxybergamo...

    6',7'-Dihydroxybergamottin(DHB), a well-known inhibitor of CYP3A4, the inhibition of CYP3A4 activity by DHB includes the inhibition of POR activity, DHB can inhibit nifedipine oxidation in a concentration-dependent manner.

  • Grandifloroside

    Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).